Answer
Kiovig is administered by intravenous infusion, initially at 0.5 ml/kg body weight/hour for 30 minutes, gradually increasing if tolerated to 6 ml/kg/hour; limited clinical data indicate that some adults with primary immunodeficiency may tolerate up to 8 ml/kg/hour.
Sources for this answer
- KIOVIG 100 mg/ml solution for infusionTakeda UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 9Document updated
Sources checked